Nil deviation in use of warrant proceeds for quarter ended 30 September 2026
KIMS shared its quarterly statement on funds raised via warrants to the Promoter & Promoter group.
By ScoutQuest · · 2 min read
- Amount raised via warrants
- Rs. 600 Cr raised on 19th August, 2026; Rs. 150 Cr (25%) received
- Deviation or variation
- NIL deviation or variation for the quarter ended 30th September, 2026
- Utilisation by object
- Rs. 150 Cr used for General Corporate Purposes; debt-repayment portions unutilised so far
What the company reported
- The company shared its statement of deviation or variation for the quarter ended 30th September, 2026, covering funds raised through issue of Warrants to the Promoter & Promoter group.
- It confirmed there was NIL deviation or variation in the utilisation of these proceeds from the objects stated in the Postal Ballot Notice dated 15th June, 2026.
- The Audit Committee, in its meeting held on 4th November, 2026, noted that there is NIL deviation or variation in the utilisation of the funds.
- The comments of the auditors, if any, are shown as None.
The fund-raising numbers
- Date of raising funds: 19th August, 2026.
- Amount Raised: Rs. 600 Cr.
- Amount Received: Rs. 150 Cr, described as 25% of the amount raised.
- Monitoring Agency: Applicable; CARE Ratings Limited is named as the monitoring agency.
Where the money is earmarked
- Repayment or prepayment, in full or part, of certain outstanding borrowings of KIMS: original allocation Rs. 260.00 crore; funds utilised Rs. 0.00 crore.
- Investment into KIMS Hospitals Bengaluru Private Limited and Arunodaya Hospitals Private Limited for repayment or prepayment of their borrowings: original allocation Rs. 190.00 crore; funds utilised Rs. 0.00 crore.
- General Corporate Purposes: original allocation Rs. 150.00 crore; funds utilised Rs. 150.00 crore.
- Total original allocation Rs. 600.00 crore; amount received Rs. 150.00 crore; amount of deviation or variation for the quarter is NIL against each object.
How to read this
This is a routine quarterly check that tells investors whether money raised was used for the purposes it was taken for. Here the answer is that nothing changed: the objects and their allocations are as originally stated, and the deviation column shows Nil for every head.
Of the Rs. 150 Cr received so far, the entire amount has gone to General Corporate Purposes, which is the smallest of the three allocations at Rs. 150.00 crore. The two debt-repayment heads, which together account for Rs. 450.00 crore of the Rs. 600.00 crore plan, show Rs. 0.00 crore utilised for the quarter.
Because only 25% of the amount raised has been received, the picture on utilisation will build up as the remaining portion comes in over time.
In short
The update carries no change in the use of funds and no reported deviation, which is the compliance-relevant takeaway for the quarter.
Also from Krishna Institute of Medical Sciences
QIP utilisation: NIL deviation or variation for quarter ended 30 September 2026
4 Nov 2026
Monitoring Agency Report: Rs. 150 crore warrant money received, nil utilised in Q2
4 Nov 2026
QIP monitoring report: ₹1,500 crore raised, ₹1,332 crore utilised, nil deviation from objects
4 Nov 2026
More numbers
- Amount RaisedRs. 600 Cr
- Amount Received (25% of amount raised)Rs. 150 Cr
- Share of amount raised received25%
- Original allocation - repayment of KIMS borrowings260.00
- Original allocation - investment in subsidiaries190.00
- Original allocation - General Corporate Purposes150.00
- Funds utilised - General Corporate Purposes150.00
- Total original allocation600.00
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.